← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Auxagen, Inc.
Saint Louis, MO
$2,066,429
Total funding
6
Grants
Funding over time
peak $504.9K · FY2006–16$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,066,429 · 6
By mechanism
R44$998,034 · 1
R43$686,739 · 3
R41$381,656 · 2
Investigators at Auxagen, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
TGF-beta Antagonists for Accelerating Wound Healing$504,929
R44 · FY2011 · AR
TGF-beta Antagonists for Accelerating Wound Healing$493,105
R44 · FY2010 · AR
A Novel TGF-β Receptor Antagonist to Treat Pulmonary Fibrosis$283,567
R43 · FY2016 · HL
A Therapeutic Agent for Radiation-induced Lung Fibrosis$227,692
R43 · FY2009 · HL
Novel Antagonists for Ameliorating Pulmonary Fibrosis$199,467
R41 · FY2007 · HL
Novel Therapeutic Agents for Diabetic Ulcers$182,189
R41 · FY2008 · DK
TGF-Beta Antagonists for Accelerating Wound Healing$175,480
R43 · FY2006 · AR